Press release
New Book "Reward" Unveils International Manhunt and Legal Drama
New Book by International Arbitrator Mark Cymrot Chronicles an Unbelievable True Story of Spies, Lawsuits, and JusticeImage: https://www.abnewswire.com/uploads/e0fc21f6603a92952ec2b0d20cf44cbe.jpg
Washington, D.C. - Mark Cymrot, a renowned international arbitrator, and litigator, unveils an extraordinary legal thriller in his latest book, Reward. Drawing readers into a real-life spy drama, the book delves into the complex and controversial case of Jose Guevara v. Republic of Peru, a story that spans international espionage, a multi-million-dollar reward, and a lawsuit that rattled governments in three countries.
At the heart of Reward is the high-profile capture of Vladimiro Montesinos, Peru's notorious former National Security chief. Montesinos, infamous for his involvement in numerous crimes, fled justice, sparking an international manhunt. Jose Guevara, a Venezuelan spy, claimed to have played a pivotal role in Montesinos' capture, demanding the $5 million reward offered by the Peruvian government. What followed was a courtroom battle that captivated global attention, as Guevara sued Peru for reneging on the reward, and Mark Cymrot stepped in to defend the nation.
Through a meticulous exploration of court documents, secret negotiations, and high-stakes cross-examinations, Reward provides readers with a rare behind-the-scenes look at the intersection of law, politics, and international intrigue. As the story unfolds, Cymrot uncovers a hidden truth that changes the course of the lawsuit, leading to a U.S. Court of Appeals rebuke of Peru before a dramatic reversal of fortunes.
"Reward reads like the latest spy thriller, yet it is a true story that captivated the legal world," said Cymrot, whose decades-long career in international arbitration has earned him a reputation as one of the most accomplished legal minds of his generation. "This case was about much more than just money-it was about justice, integrity, and the complex relationships between nations."
Mark Cymrot's credentials are as compelling as the cases he chronicles. He has served as lead counsel in numerous high-profile arbitrations and lawsuits, including a $197 million verdict in the infamous silver market manipulation case, one of the top 10 jury verdicts of its decade. He has represented countries like Peru in disputes involving billions of dollars, reshaping economies, and defending national interests on the world stage.
In Reward, Cymrot brings his expertise as both a lawyer and a storyteller, offering readers insights into the art of persuasion, courtroom strategy, and the nuances of international law. Legal professionals and thriller enthusiasts alike will find the book to be a gripping read, full of twists and turns reminiscent of a spy novel.
Praise for Mark Cymrot and Reward:
"A captivating account of a spectacular legal drama." - Kirkus Reviews
"A real-life Perry Mason story." - Bernie Swain, Founder, Washington Speakers Bureau
"A personal journey to the front lines of an international legal battle brimming with suspense and intrigue." - Ann Hagedorn, award-winning author
Reward is now available at major book retailers. For more information, visit www.markcymrot.com [http://www.markcymrot.com/]
About Mark Cymrot
Mark Cymrot is a globally recognized international arbitrator and litigator with extensive experience in high-stakes cases around the world. He is the author of several books and a frequent speaker on topics related to international law and arbitration.
Media Contact
Company Name: Mark Cymrot
Contact Person: Mark Cymrot
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=new-book-reward-unveils-international-manhunt-and-legal-drama]
Country: United States
Website: http://www.markcymrot.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release New Book "Reward" Unveils International Manhunt and Legal Drama here
News-ID: 3736874 • Views: …
More Releases from ABNewswire

Lyme Disease Market: Insights on Epidemiology, Treatments, and Leading Companies …
The Emerging Lyme Disease Drugs include - VLA-15, TP-05, mRNA-1982 & mRNA-1975, and others
Emerging therapies for Lyme disease, including VLA15, mRNA-1975, TP-05, mRNA-1982, and others, are expected to drive growth in the Lyme disease market in the coming years.
DelveInsight has released a new report titled "Lyme Disease - Market Insights, Epidemiology, and Market Forecast-2034", offering a comprehensive analysis of the disease, covering historical and projected epidemiology as well as market…

Knee osteoarthritis Market: Epidemiology, Therapies, Companies, DelveInsight | C …
Knee osteoarthritis is more prevalent in females than males, accounting for nearly 60% and 40% cases respectively.
Knee osteoarthritis therapies, such as CINGAL, DUROLANE, TLC599, CNTX-4975, and others, are expected to boost the Knee osteoarthritis Market in the upcoming years.
DelveInsight has launched a new report on "Knee osteoarthritis - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Knee osteoarthritis, historical and forecasted epidemiology as well as…

Cystinosis Market: Epidemiology, Therapies, Companies, DelveInsight | Horizon Ph …
The Cystinosis Treatment Market is poised to change with increased competition among pharmaceutical companies, potentially leading to improved accessibility, affordability, and innovation in treatment options. Additionally, advancements in gene therapy and precision medicine may reshape treatment paradigms.
Emerging therapies for Cystinosis, including NPI-001 and others, are anticipated to drive growth in the Cystinosis market in the coming years.
DelveInsight has released a new report titled "Cystinosis - Market Insights, Epidemiology, and Market…

Acute Bacterial Skin and Skin-Structure Infection (ABSSSI) Market: Insights into …
As per secondary analysis, ABSSSI accounted for almost 870,000 hospital admissions in the United States in 2004 which represents an increase of almost 30% in the incidence of this diagnosis over a 4-year period.
Emerging therapies for acute bacterial skin and skin-structure infections (ABSSSI), including DALVANCE (dalbavancin), ORBACTIV, MRX-4, ZEVTERA (ceftobiprole), and others, are anticipated to drive growth in the ABSSSI market in the coming years.
DelveInsight has published a new report…